Gastric tonometry: The hemodynamic monitor of choice (Pro)HEARD, Stephen O.Chest. 2003, Vol 123, Num 5, pp 469S-474S, issn 0012-3692, SUPArticle

Care of the injured Jehovah's Witness patient: Case report and review of the literatureKULVATUNYOU, Narong; HEARD, Stephen O.Journal of clinical anesthesia. 2004, Vol 16, Num 7, pp 548-553, issn 0952-8180, 6 p.Article

Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammationTHIEMERMANN, Christoph.Critical care medicine. 2003, Vol 31, Num 1, pp S76-S84, issn 0090-3493, SUPArticle

A subclavian artery injury, secondary to internal jugular vein cannulation, is a predictable right-sided phenomenonKULVATUNYOU, Narong; HEARD, Stephen O; BANKEY, Paul E et al.Anesthesia and analgesia. 2002, Vol 95, Num 3, pp 564-566, issn 0003-2999Article

Cutting Edge TherapeuticsFINK, Mitchell P; HEARD, Stephen O.Critical care medicine. 2003, Vol 31, Num 1, issn 0090-3493, 119 p., SUPSerial Issue

Airway management in critical illnessWALZ, J. Matthias; ZAYARUZNY, Maksim; HEARD, Stephen O et al.Chest. 2007, Vol 131, Num 2, pp 608-620, issn 0012-3692, 13 p.Article

Role of flagellin in the pathogenesis of shock and acute respiratory distress syndrome: Therapeutic opportunitiesSZABO, Csaba.Critical care medicine. 2003, Vol 31, Num 1, pp S39-S45, issn 0090-3493, SUPArticle

In vitro exposure of bacteria to antimicrobial impregnated-central venous catheters does not directly lead to the emergence of antimicrobial resistanceMUNSON, Erik L; HEARD, Stephen O; DOERN, Gary V et al.Chest. 2004, Vol 126, Num 5, pp 1628-1635, issn 0012-3692, 8 p.Article

An evaluation of a new continuous Blood pressure monitoring system in critically ill patientsHEARD, Stephen O; LISBON, Alan; TOTH, Ildiko et al.Journal of clinical anesthesia. 2000, Vol 12, Num 7, pp 509-518, issn 0952-8180Article

Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicineSALVEMINI, Daniela; CUZZOCREA, Salvatore.Critical care medicine. 2003, Vol 31, Num 1, pp S29-S38, issn 0090-3493, SUPArticle

Ethyl pyruvate: A novel anti-inflammatory agentFINK, Mitchell P.Critical care medicine. 2003, Vol 31, Num 1, pp S51-S56, issn 0090-3493, SUPArticle

Restrictive antibiotic policies are appropriate in intensive care unitsPATERSON, David L.Critical care medicine. 2003, Vol 31, Num 1, pp S25-S28, issn 0090-3493, SUPArticle

Nuclear factor-κB as a therapeutic target in critical care medicineZINGARELLI, Basilia; SHEEHAN, Maeve; WONG, Hector R et al.Critical care medicine. 2003, Vol 31, Num 1, pp S105-S111, issn 0090-3493, SUPArticle

Proteomics and systems biology approaches to signal transduction in sepsisNGUYEN, Anhco; YAFFE, Michael B.Critical care medicine. 2003, Vol 31, Num 1, pp S1-S6, issn 0090-3493, SUPArticle

Outpatient tympanomastoidectomy : Factors affecting hospital admissionMEGERIAN, Cliff A; REILY, Jackie; O'CONNELL, Frank M et al.Archives of otolaryngology, head & neck surgery. 2000, Vol 126, Num 11, pp 1345-1348, issn 0886-4470Article

Surgical site infection following bowel surgery : A retrospective analysis of 1446 patientsMATTHIAS WALZ, J; PATERSON, Craig A; SELIGOWSKI, Jeanne M et al.Archives of surgery (Chicago, IL. 1960). 2006, Vol 141, Num 10, pp 1014-1018, issn 0004-0010, 5 p.Article

Targeting high mobility group box 1 as a late-acting mediator of inflammationCZURA, Christopher J; TRACEY, Kevin J.Critical care medicine. 2003, Vol 31, Num 1, pp S46-S50, issn 0090-3493, SUPArticle

Endotoxin as a drug targetOPAL, Steven M; GLÜCK, Thomas.Critical care medicine. 2003, Vol 31, Num 1, pp S57-S64, issn 0090-3493, SUPArticle

Therapeutic potential of targeting the complement cascade in critical care medicineBHOLE, Deepak; STAHL, Gregory L.Critical care medicine. 2003, Vol 31, Num 1, pp S97-S104, issn 0090-3493, SUPArticle

Economic evaluation of new therapies in critical illnessCOUGHLIN, Michael T; ANGUS, Derek C.Critical care medicine. 2003, Vol 31, Num 1, pp S7-S16, issn 0090-3493, SUPArticle

Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Pro and conBERNARD, Gordon R; EICHACKER, Peter Q; NATANSON, Charles et al.Critical care medicine. 2003, Vol 31, Num 1, pp S85-S96, issn 0090-3493, SUPArticle

How to leverage an endogenous immune defense mechanism: The example of granulocyte colony-stimulating factorHARTUNG, Thomas; VON AULOCK, Sonja; SCHNEIDER, Christian et al.Critical care medicine. 2003, Vol 31, Num 1, pp S65-S75, issn 0090-3493, SUPArticle

Investigation of muscle pH as an indicator of liver pH and injury from hemorrhagic shockSOLLER, Babs R; KHAN, Tania; FAVREAU, Janice et al.The Journal of surgical research. 2003, Vol 114, Num 2, pp 195-201, issn 0022-4804, 7 p.Article

An evaluation of the diagnostic accuracy of the 1991 American College of Chest Physicians/Society of Critical Care Medicine and the 2001 Society of Critical Care Medicine/European Society of Intensive Care Medicine/American College of Chest Physicians/American Thoracic Society/Surgical Infection Society sepsis definitionHUIFANG ZHAO; HEARD, Stephen O; MULLEN, Marie T et al.Critical care medicine. 2012, Vol 40, Num 6, pp 1700-1706, issn 0090-3493, 7 p.Article

Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumoniaDICKSON, Eric W; HEARD, Stephen O; TARARA, Thomas E et al.Critical care medicine. 2002, Vol 30, Num 2, pp 393-395, issn 0090-3493Article